In this episode, I’ll discuss predictors of oversedation in hospitalized patients. Subscribe on iTunes, Android, or Stitcher Opioid-induced respiratory depression (OIRD) and oversedation are significant risks to patient safety in the hospital. The ability to predict patients at risk for these consequences of opioid use could allow for monitoring to be increased and potentially less […]
Episode 400: Acetazolamide as a respiratory stimulant
In this episode, I’ll discuss acetazolamide’s use as a respiratory stimulant in ICU patients. Subscribe on iTunes, Android, or Stitcher Acetazolamide is a carbonic anhydrase inhibitor that has indications for use in altitude sickness, edema, and elevated intraocular pressure. However, acetazolamide also has potentially useful properties as a respiratory stimulant for certain ICU patients. Patients […]
Episode 399: The biggest risk to using phenobarbital monotherapy for severe alcohol withdrawal
In this episode, I’ll discuss the biggest risk to using phenobarbital monotherapy for severe alcohol withdrawal. Subscribe on iTunes, Android, or Stitcher Phenobarbital is a very effective option for treating severe alcohol withdrawal. A recent retrospective analysis of 3 protocols – one using diazepam alone, one using lorazepam and phenobarbital and one using phenobarbital alone […]
Episode 398: Apixaban in patients at extremes of body weight and the Cortosyn shortage
In this episode I’ll: 1. Discuss an article about the safety and efficacy of apixaban in patients at extremes of body weight. 2. Answer a drug information question about the diagnosis of adrenocortical insufficiency without using Cortosyn. Subscribe on iTunes, Android, or Stitcher Article Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial […]
Episode 397: An update on research for hydrocortisone, ascorbic acid, and thiamine (HAT Rx) for sepsis
In this episode, I’ll discuss the state of research for hydrocortisone, ascorbic acid, and thiamine (HAT Rx) for sepsis. Subscribe on iTunes, Android, or Stitcher It has been nearly 2 and a half years since the publication of Paul Marik’s retrospective before-after study of hydrocortisone, ascorbic acid, and thiamine to treat septic shock. According to […]
Episode 396: The use of methylene blue for the treatment of refractory anaphylaxis without hypotension
In this episode, I’ll discuss the use of methylene blue for the treatment of refractory anaphylaxis without hypotension. Subscribe on iTunes, Android, or Stitcher Methylene blue has some unique uses such as in the treatment of acquired methemoglobinemia and vasoplegia after cardiac surgery. It also appears to have a role in treating patients experiencing anaphylaxis […]
Episode 395: PGY-1 Learning Activities and the 6 levels of Bloom’s Learning Taxonomy
In this episode, I’ll discuss PGY-1 Learning Activities and the 6 levels of Bloom’s Learning Taxonomy. Subscribe on iTunes, Android, or Stitcher ASHP accreditation standards mandate that : Learning activities are developed at the cognitive learning level (Bloom’s Taxonomy) associated with the objective. The 6 levels of cognitive learning according to Bloom’s are: Level 1: […]
Episode 394: The use of ketamine for agitation in patients with schizophrenia and simultaneous use of oral and IV vancomycin
In this episode I’ll: 1. Discuss an article about the use of ketamine for agitation in patients with schizophrenia 2. Answer the drug information question “Can oral and IV vancomycin be given at the same time to the same patient?” Subscribe on iTunes, Android, or Stitcher Article Psychiatric Outcomes of Patients With Severe Agitation […]
Episode 393: Why is IV dextrose given to patients with DKA?
Subscribe on iTunes, Android, or Stitcher Why is IV dextrose given to patients with DKA? When the serum glucose reaches 200 mg/dL in a patient with diabetic ketoacidosis (DKA), IV dextrose is added to avoid the development of cerebral edema. In addition, the rate of insulin infusion may need to be slowed down to between […]
Episode 392: How to remember antibiotic spectrum of activity
In this episode, I’ll discuss how to remember antibiotic spectrum of activity. Subscribe on iTunes, Android, or Stitcher Knowing the antibiotic spectrum of activity Early in my career, I asked an ID physician how he kept track of the spectrum of activity for all the antibiotics (Shout out to “Infectious Disease Phil”). He told me […]
Episode 391: Is 100 mg of micafungin enough for critically ill obese patients?
In this episode, I’ll discuss whether 100 mg of micafungin is enough for critically ill obese patients. Subscribe on iTunes, Android, or Stitcher The recommended dose of micafungin for candidemia is 100mg, but is this enough to achieve adequate levels in obese patients? A meta-analysis published in the journal Critical Care attempts to answer this […]
Episode 390: What is the role for tranexamic acid in the treatment of epistaxis?
In this episode, I’ll discuss the role for tranexamic acid in the treatment of epistaxis. Subscribe on iTunes, Android, or Stitcher Tranexamic acid is an antifibrinolytic agent. It works by forming a reversible complex that displaces plasminogen from fibrin. This results in the inhibition of fibrinolysis. Tranexamic acid has been used in oral or topical […]
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 83
- Next Page »